# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
RBC Capital analyst Ben Hendrix maintains Select Medical Hldgs (NYSE:SEM) with a Outperform and raises the price target from...
B of A Securities analyst Joanna Gajuk maintains Select Medical Hldgs (NYSE:SEM) with a Buy and lowers the price target from...
UBS analyst A.J. Rice maintains Select Medical Hldgs (NYSE:SEM) with a Neutral and lowers the price target from $15 to $14.
Select Medical Hldgs (NYSE:SEM) affirms FY2025 GAAP EPS guidance from $1.09-$1.19 to $1.09-$1.19 vs $1.11 analyst estimate. Aff...
Select Medical Hldgs (NYSE:SEM) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0....